Immunohistochemistry also demonstrated the loss of RB1 expression in the tumor cells (Fig. 3E, Table S1), suggesting that the leiomyosarcoma might have occurred as a secondary cancer on the background of RB. The gene discussed is RB1; the disease is cancer.